Suppr超能文献

[新型抗癫痫药物血清水平监测]

[Monitoring serum levels of new antiepileptics].

作者信息

Armijo J A, Adín-Ibarra J, Sánchez-Baglietto N, Vega-Gil N

机构信息

Servicio de Farmacología Clínica. Hospital Universitario Marqués de Valdecilla. Santander, España.

出版信息

Rev Neurol. 2002 Sep;35 Suppl 1:S116-34.

Abstract

AIM

Therapeutic monitoring of old antiepileptic drugs has been useful in improving their use in clinical practice. The new antiepileptic drugs have been developed with the idea that monitoring their serum levels was going to be unnecessary. We review the characteristics of the new antiepileptic drugs that can be relevant to their being monitored and their possible uses.

DEVELOPMENT

After discussion of the evolution of the therapeutic monitoring of antiepileptic drugs in general, we take a more detailed look at the requirements needed for it to be useful, such as the indications, the procedure and a correct interpretation of the results. We point out the reasons why monitoring the new antiepileptic drugs can be worthwhile and we examine the characteristics of felbamate, gabapentin, lamotrigine, oxcarbazepine, tiagabine, topiramate, vigabatrin and zonisamide which may be relevant in their monitoring. These include the type of kinetics, the factors that have an influence on the relationship between dosage and serum levels, the concentration/dose ratio, data on the relationship between serum levels and effects, the factors that can influence this relationship, as well as the characteristics of sampling.

CONCLUSION

The new antiepileptic drugs present a wide interindividual and intraindividual variability which leads us to believe that some of they may be suitable candidates for therapeutic monitoring, but at present no target ranges have been clearly defined for any of them. Therefore, routine monitoring cannot be recommended, but it may be useful to establish an individual reference level that allows control over compliance and dosage readjustment in the presence of factors that alter their pharmacokinetics. Specific prospective studies are needed to establish target ranges that allow to individualize dosage in the absence of clinical criteria and to resolve doubts about the efficacy and toxicity of these drugs. Quicker and simpler assays that make monitoring easier are also needed.

摘要

目的

对传统抗癫痫药物进行治疗监测有助于改善其在临床实践中的应用。新型抗癫痫药物的研发基于无需监测其血清水平的理念。我们回顾了新型抗癫痫药物中可能与其监测相关的特性及其潜在用途。

进展

在总体讨论抗癫痫药物治疗监测的演变之后,我们更详细地探讨了使其有用所需的要求,如适应证、操作流程以及对结果的正确解读。我们指出监测新型抗癫痫药物值得进行的原因,并研究了非氨酯、加巴喷丁、拉莫三嗪、奥卡西平、噻加宾、托吡酯、氨己烯酸和唑尼沙胺在监测方面可能相关的特性。这些特性包括动力学类型、影响剂量与血清水平关系的因素、浓度/剂量比、血清水平与疗效关系的数据、可影响这种关系的因素以及采样特性。

结论

新型抗癫痫药物存在广泛的个体间和个体内变异性,这使我们认为其中一些可能适合进行治疗监测,但目前尚未为它们中的任何一种明确界定目标范围。因此不建议进行常规监测,但在存在改变其药代动力学的因素时,建立个体参考水平以控制依从性和调整剂量可能是有用的。需要开展特定的前瞻性研究来确定目标范围,以便在缺乏临床标准的情况下实现剂量个体化,并解决对这些药物疗效和毒性的疑问。还需要更快、更简单的检测方法以使监测更简便。

相似文献

4
Therapeutic monitoring of the new antiepileptic drugs.新型抗癫痫药物的治疗监测
Eur J Clin Pharmacol. 2000 Jan;55(10):697-705. doi: 10.1007/s002280050001.
5
[Newer antiepileptic drugs].新型抗癫痫药物
Brain Nerve. 2007 Feb;59(2):147-56.
10
Therapeutic drug monitoring of the newer antiepileptic drugs.新型抗癫痫药物的治疗药物监测
Ther Drug Monit. 2003 Jun;25(3):347-63. doi: 10.1097/00007691-200306000-00016.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验